Tag: Sanofi

Joint efforts to fight diabetes

A Memorandum on Strategic Partnership in the Area of Non-Communicable Diseases was signed between Sanofi; Health of the Nation League, an All-Russian public organization; and Healthy Cities, Districts and Villages Association.

Sanofi will modernize its insulin production facility in Russia

Sanofi announced a new stage in the modernization of its insulin production facility at Sanofi-Aventis Vostok plant in the Orel region as part of the long-term investment strategy in Russia.

Advent International will acquire Sanofi’s generics subsidiary Zentiva

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.

Sanofi will pump €350 million into construction of its new Canadian facility

Sanofi, a leading global pharmaceutical company, is investing €350 million for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.

Evotec and Sanofi will create a new innovation platform in France

test tube
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.

WHO approved Shantha Biotechnics cholera vaccine

Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine. The approval is for use at temperatures as h...

Sanofi licenses universal influenza vaccine technology from SK Chemicals

SK Chemicals Co., a South Korean vaccine maker, signed $155 million deal to license cell culture technology to Sanofi Pasteur Inc. for development of a universal influenza vaccine

Sanofi acquires a Belgian biopharmaceutical company

Sanofi and Ablynx, a biopharmaceutical company engaged in development of Nanobodies, entered into a definitive agreement under which Sanofi will offer to acquire Ablynx at a price of approximately €3.9 billion

Sanofi buys Bioverativ biopharmaceutical company

Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia, have entered into a agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ

Sanofi Pasteur will pay $27.8 million to Philippines for the dengue vaccine

malaria vaccine
French pharmaceutical giant Sanofi agreed to reimburse the Philippine government for leftover doses of an anti-dengue vaccine whose use was suspended due to health concerns, the two parties said

Evotec and APEIRON reached the first landmark in their alliance with Sanofi

research lab
Evotec AG and APEIRON Biologics AG announced that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015

Sanofi and Meshalkin National Medical Research Center sign a joint memorandum

Sanofi and Meshalkin National Medical Research Center signed a memorandum aimed at strategic partnership

Russian pharma companies are registering medicines in more than 60 countries

When Pharma-2020 was launched in 2010, its first priority was to provide domestically manufactured medicines

Russian pharmaceutical market reaches 863 billion rubles in Q1-Q3

According to AlphaRM, September 2017 ended with the growth in the retail segment and fall in the public segment of the pharmaceutical market

Sanofi and Principia Biopharma will develop a treatment of multiple sclerosis

Sanofi signed a license agreement with Principia Biopharma Inc. to develop an experimental oral treatment for multiple sclerosis

Sanofi and AstraZeneca signed SPICs with the Russian Ministry

On October 16, Sanofi and AstraZeneca signed special investment contracts (SPICs) with the Russian Ministry of Industry and Trade and Russian regions